These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6452856)

  • 21. Antibodies to gangliosides and myelin proteins in Guillain-Barré syndrome.
    Quarles RH; Ilyas AA; Willison HJ
    Ann Neurol; 1990; 27 Suppl():S48-52. PubMed ID: 2194427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum antibodies to peripheral nerve tissue in acute Guillain-Barré syndrome in relation to outcome of plasma exchange.
    Osterman PO; Vedeler CA; Ryberg B; Fagius J; Nyland H
    J Neurol; 1988 May; 235(5):285-9. PubMed ID: 3385444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Class and IgG subclass distribution of antibodies against peripheral nerve myelin in sera from patients with inflammatory demyelinating polyradiculoneuropathy.
    Vedeler CA; Matre R; Nyland H
    Acta Neurol Scand; 1988 Nov; 78(5):401-7. PubMed ID: 2464267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extra- and intrathecal production of antinerve and antibrain antibodies in Guillain-Barré syndrome: evaluation by an antibody index.
    Ryberg B
    Neurology; 1984 Oct; 34(10):1378-81. PubMed ID: 6541314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mimicry in Guillain-Barré syndrome.
    Sheikh KA; Ho TW; Nachamkin I; Li CY; Cornblath DR; Asbury AK; Griffin JW; McKhann GM
    Ann N Y Acad Sci; 1998 Jun; 845():307-21. PubMed ID: 9668364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma exchange in Guillain-Barré syndrome: effect on anti-peripheral nerve myelin antibodies.
    Vedeler CA; Nyland H
    Acta Neurol Scand; 1990 Aug; 82(2):147-9. PubMed ID: 2256446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guillain-Barré syndrome: an update.
    Vucic S; Kiernan MC; Cornblath DR
    J Clin Neurosci; 2009 Jun; 16(6):733-41. PubMed ID: 19356935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
    Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
    Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiologic studies in the Guillain-Barré syndrome: effects of plasma exchange and antibody rebound.
    Rudnicki S; Vriesendorp F; Koski CL; Mayer RF
    Muscle Nerve; 1992 Jan; 15(1):57-62. PubMed ID: 1732763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum antibodies to GM1 and GM3-gangliosides in systemic lupus erythematosus with chronic inflammatory demyelinating polyradiculoneuropathy.
    Sindern E; Stark E; Haas J; Steck AJ
    Acta Neurol Scand; 1991 Jun; 83(6):399-402. PubMed ID: 1887763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schmidt-Lanterman's incisures--the principal target of autoimmune attack in demyelinating Guillain-Barré syndrome?
    Görtzen A; Schlüter S; Veh RW
    J Neuroimmunol; 1999 Feb; 94(1-2):58-65. PubMed ID: 10376936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral nerve P2 basic protein and the Guillain-Barré syndrome. In vitro demonstration of P2-specific antibody-secreting cells.
    Luijten JA; De Jong WA; Demel RA; Heijnen CJ; Ballieux RE
    J Neurol Sci; 1984; 66(2-3):209-16. PubMed ID: 6085109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin.
    Fredman P; Vedeler CA; Nyland H; Aarli JA; Svennerholm L
    J Neurol; 1991 Apr; 238(2):75-9. PubMed ID: 1856740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guillain-Barré as an autoimmune disease.
    Shoenfeld Y; George J; Peter JB
    Int Arch Allergy Immunol; 1996 Apr; 109(4):318-26. PubMed ID: 8634515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Observations on the effect of injection of lymphocytes from multiple sclerosis and Guillain-Barré syndrome in the rabbit eye model.
    Kam-Hansen S; Kristensson K; Link H
    J Neurol Sci; 1979 Jul; 42(2):283-9. PubMed ID: 479915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody binding to PNS myelin proteins in acute Guillain-Barré syndrome.
    Shuman S; Zweiman B; Lisak R; Kahn S; Rostami A; Sumner A
    Pathol Immunopathol Res; 1988; 7(3):162-8. PubMed ID: 3194353
    [No Abstract]   [Full Text] [Related]  

  • 37. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
    Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
    J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases.
    Van den Berg LH; Mollee I; Wokke JH; Logtenberg T
    J Neuroimmunol; 1995 Apr; 58(1):37-42. PubMed ID: 7730448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Association of IgA anti-GM1 antibody with antecedent diarrhea in patients with Guillain-Barré syndrome].
    Koga M; Yuki N; Hirata K
    Rinsho Shinkeigaku; 1997 Sep; 37(9):848-50. PubMed ID: 9431003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demyelinating neuropathy associated with hepatitis B virus infection. Detection of immune complexes composed of hepatitis B virus surface antigen.
    Tsukada N; Koh CS; Inoue A; Yanagisawa N
    J Neurol Sci; 1987 Feb; 77(2-3):203-16. PubMed ID: 3029335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.